Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2007-10-23
2007-10-23
Nickol, Gary B. (Department: 1646)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C424S192100, C435S069700, C530S300000, C530S402000
Reexamination Certificate
active
10123905
ABSTRACT:
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
REFERENCES:
patent: 6590075 (2003-07-01), Ruben et al.
Sen, Curr. Opin. Oncol. vol. 12, pp. 82-88, 2000.
Pennica et al. , PNAS USA, vol. 95, pp. 14717-14722, 1998.
Gygi et al. Molecular and Cellular Biology, vol. 19, pp. 1720-1730, 1999.
Hu et al. (2003, Journal of Proteome Research 2:405-412.
Saito-Hisaminato et al, DNA Res 2002, 9:35-45.
Bustin et al., TRENDS in Molec. Med. 8(6): 269-272, 2002.
Anderson et al., Electrophoresis, vol. 18, pp. 533-537, 1997.
Kawamoto et al., Gene, 1996, vol. 174, pp. 151-158.
Lian et al., 2001, Blood 98:513-524.
Fessler et al., 2002, J. Biol. Chem. 277:31291-31302.
Lucentini (2004) “Gene Association Studies are Typically Wrong”, The Scientist, 18(24): 20.
Haviv, et a1. (2002) Molec. Cell. Endocrin., 191: 121-26.
Wu (2001) J. Pathol., 195: 53-65.
Bertucci, et al. (2000) Human Molec. Genet., 9(20): 2981-91.
Greenbaum, et al. Genome Biology, (2003), vol. 4, Issue 9, Article 117, pp. 117.1-117.8.
Genes VI, Benjamin Lewin, 1997, excert from chapter 29 (includes pp. 847-848).
Database Search, DNA sequence alignments [BLASTN 2.2.1 (Jul. 12, 2001), NCBI] A1-A30.
Database Search, protein sequence alignments [BLASTN 2.2.1 (Jul. 12, 2001), NCBI] B1-B7.
Dayhoff, Accession No. P—AAB65173, WO 200073454-A1, Pub Date: Dec. 7, 2000, Ashkenazi, A. J., et al.
Dayhoff, Accession No. P—AAB94830, EP 1074617-A2, Pub Date: Feb. 7, 2001, Ota, T., et al.
Dayhoff, Accession No. P—AAU12370, WO 200140466-A2, Pub Date: Jun. 7, 2001, Baker, K. P., et al.
Dayhoff, Accession No. P—AAY50944, WO 9955721-A1, Pub Date: Nov. 4, 1999, Valenzuela, D., et al.
Dayhoff, Accession No. P—AAY66650, WO 9963088-A2, Pub Date: Dec. 9, 1999, Baker, K., et al.
Dayhoff, Accession No. P—AAY06940, WO 9916870-A1, Pub Date: Apr. 8, 1999, Sheppard, P. O.
Dayhoff, Accession No. AAH08742.1, Direct Submission, Submitted: May 25, 2001, National Institute of Health.
Dayhoff, Accession No. AAD22397.1, Direct Submission, Submitted: Jun. 15, 1998, Sheppard, P., et al.
Dayhoff, Accession No. NP—057010.1, Genome Research, vol. 13, No. 10, pp. 2265-2270, 2003, Clark H.F., et al.
Dayhoff, Accession No. P—AAW75156, WO 9839446-A2, Pub Date: Sep. 11, 1998, Ruben, S. M., et al.
Dayhoff, Accession No. P—AAB75371, WO 200100806-A2, Pub. Date: Jan. 4, 2001, Dumas Milne, E. J., et al.
Dayhoff, Accession No. P—AAB25785, WO 200037491-A2, Pub. Date: Jun. 29, 2000, Bougueleret, L., et al.
Dayhoff, Accession No. CAC25002.1, WO 0100806-A, Pub. Date: Jan. 4, 2001, Dumas Milne, E. J., et al.
GenBank, Accession No. P—AAS21442, WO 200140466-A2, Pub Date: Jun. 7, 2001, Baker, K. P., et al.
GenBank, Accession No. P—AAF44117, WO 200073454-A1, Pub Date: Dec. 7, 2000, Ashkenazi, A. J., et al.
GenBank, Accession No. P—AAZ43806, WO 9955721-A1, Pub Date: Nov. 4, 1999, Valenzuela, D., et al.
GenBank, Accession No. P—AAZ64971, WO 9963088-A2, Pub Date: Dec. 9, 1999, Baker, K., et al.
GenBank, Accession No. P—AAX34795, WO 9916870-A1, Pub Date: Apr. 8, 1999, Sheppard, P. O., et al.
GenBank, Accession No. AX080797, WO 0109327-A, Pub Date: Feb. 8, 2001, Ashkenazi, A. J., et al.
GenBank, Accession No. BC008742, Direct Submission, May 25, 2001, Akhter, N., et al.
GenBank, Accession No. AF072733, Direct Submission, Submitted: Jun. 15, 1998, Sheppard, P., et al.
GenBank, Accession No. NM—015926, Genome Research vol. 13, No. 10, pp. 2265-2270, 2003, Clark, H. F., et al.
GenBank, Accession No. P—AAH16771, EP 1074617-A2, Pub Date: Feb. 7, 2001, Ota, T., et al.
GenBank, Accession No. AK023997, Direct Submission, Submitted: Aug. 23, 2000, Isogai, T., et al.
GenBank, Accession No. BC001592, Direct Submission, Dec. 22, 2000, Strausberg, R. L., et al.
GenBank, Accession No. P—AAF64029, WO 200100806-A2, Pub Date: Jan. 4, 2001, Dumas Milne, E. J., et al.
GenBank, Accession No. P—AAA87747, WO 200037491-A2, Pub Date: Jun. 29, 2001, Bougueleret, L., et al.
GenBank, Accession No. AX061641, WO 0100806-A, Pub Date: Jan. 4, 2001, Dumas Milne, E. J., et al.
GenBank, Accession No. P—AAV34253, WO 9839446-A2, Pub Date: Sep. 11, 1998, Ruben, S. M., et al.
GenBank, Accession No. P—AAV34195, WO 9839446-A2, Pub Date: Sep. 11, 1998, Ruben, S. M., et al.
Abe, N., et al., “An Increased High-Mobility Group A2 Expression Level is Associated with malignant Phenotype in Pancreatic Exocrine Tissue,”Br J Cancer—89(11):2104-9 (2003) Abstract.
Ando, M., et al., “Selective Apoptosis of Natural Killer-Cell Tumours by I-Asparaginase,”Br J Haematol.,—130(6):860-8 (2005) Abstract.
Aust, G., et al., “Human Thyroid Carcinoma Cell Lines and Normal Thyrocytes: Expression and Regulation of Matrix Metalloproteinase Inhibitor-1 Messenger-RNA and Protein,”Thyroid—7(5):713-24 (1997) Abstract.
Barnes, V.L., et al., “Expression of Embryonic Fibronectin Isoform EIIIA Parallels Alpha-Smooth Muscle Actin in Maturing and Diseased Kidney,”J Histochem Cytochem.—47(6):787-98 (1999) Abstract.
Bea, S., et al., “BMI-1 Gene Amplification and Overexpression in Hematological Malignancies Occur Mainly in Mantle Cell Lymphonas,”Cancer Res.—61(6):2409-12 (2001) Abstract.
Blaschke, V., et al., “Rapid Quantitation of Proinflammatory and Chemoattractant Cytokine Expression in Small Tissue Samples and Monocyte-Derived Dendritic Cells: Validation of a New Real-Time RT-PCR Technology,”J Immunol Methods.—246(1-2):79-90 (2000) Abstract.
Buckley, A.R., et al., “Butyrate-Induced Reversal of Dexamethasone Resistance in Autonomouse Rat Nb2 Lymphoma Cells,”Apoptosis.—2(6):518-28 (1997) Abstract.
Caberlotto, L. et al., “Alterations in Neuropeptide Y Levels and Y1 Binding Sites in the Flinders Sensitive Line Rats, A Genetic Animal Model of Depression,”Neurosci Lett.—265(3):191-4 (1999) Abstract.
Caberlotto, L., et al., “Neurokinin 1 Receptor and Relative Abundance of the Short and Long Isoforms in the Human Brain,”Eur J Neurosci.—17(9):1736-46 (2003) Abstract.
Choi, D., et al., “Characterization of Cyclin D2 Expression in Human Endometrium,”J Soc Gynecol Investig.—9(1):41-6 (2002) Abstract.
Couvelard, A., et al., “Human Chorionic Gonadotrophin Beta Expression in Malignant Barrett's Oesophagus,”Virchows Arch.—445(3);279-84 (2004) Abstract.
Dagenais, A., et al., “Downregulation of EnaC Activity and Expression by TNF-Alpha in Alveolar Epithelial Cells,”Am J. Physio Lung Cell Mol Physiol.—286(2):L301-11 (2004) Abstract.
De Boer, C.J., et al., “Involement of the CCNDI Gene in Hairy Cell Leukemia,”Ann Oncol.—7(3):251-6 (1996) Abstract.
Debieve, F., et al., “Inhibin and Activin Production and Subunit Expression in Human Placental Cells Cultured in Vitro,”Mol Hum Reprod.—6(8):743-9 (2000) Abstract.
Dong, Z., et al., “Expression of Membrane-Type Matrix Metalloproteinases 4, 5, and 6 in Mouse Corneas Infected withP. aeruginosa,” Invest Opthalmol Vis Sci—42(13):3223- (2001) Abstract.
Duchrow, M., et al., “Assessment of Proliferative Activity in Colorectal Carcinomas by Quantitative Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR),”Cancer Invest.—19(6):588-96 (2001) Abstract.
Dyer, J., et al., “Molecular Characterisation of Carbohydrate Digestion and Absorption in Equine Small Intestine,”Equine Vet J.—34(4):349-58 (2002) Abstract.
Egwuagu, C.E., et al., “Su
Goddard Audrey
Godowski Paul J.
Gurney Austin L.
Smith Victoria
Watanabe Colin K.
Barnes Elizabeth M.
Basi Nirmal S.
Dreger Ginger R.
Genentech Inc.
Kresnak Mark T.
LandOfFree
PRO536 polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with PRO536 polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PRO536 polypeptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3850858